methyl 2,4-dihydroxy-3,6-dimethyl benzoate has been researched along with Invasiveness, Neoplasm in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baniahmad, A; Claessens, F; Degen, S; Matusch, R; Papaioannou, M; Prade, I; Roell, D; Schleich, S; Schubert, U; Tanner, T | 1 |
1 other study(ies) available for methyl 2,4-dihydroxy-3,6-dimethyl benzoate and Invasiveness, Neoplasm
Article | Year |
---|---|
The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Base Sequence; Cell Division; Cell Line, Tumor; DNA Primers; Humans; Hydroxybenzoates; Male; Neoplasm Invasiveness; Polymerase Chain Reaction; Prostatic Neoplasms | 2009 |